who can prescribe a glp 1 research2guidance GLP-1 Medications for Weight Loss:

Financial support and sponsorship This work was supported by Fondo de Investigacin Sanitaria-FEDER (PI25/00528) and CIBEROBN from the Spanish Instituto de Salud Carlos III, and the Department of Health of the Gobierno de Navarra (GN2025/52)

Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying

While substantial literature exists on technical retrofitting and energy efficiency, limited empirical research explores the practicalities of decision-making, particularly how stakeholders interact and navigate trade-offs among competing priorities

Other research found that intakes of 1.1 to 1.6 g/kg preserved muscle during weight loss better than lower amounts